KrasPharma plant updated their profit results

According to industry experts, in 2020, despite the difficult situation related to quarantine due to COVID-19, Kraspharma continued its continuous and painstaking work. It was able to introduce two new technological areas and, most importantly, expand the production of pharmaceutical products necessary for State Healthcare. In its turn, it led to an expectation of $ 67 million in tax-free revenue, where net profit is more than $ 13,000,000. Accordingly, the company's profit growths are 40% compared to 2019 in terms of revenue and more than 100% in terms of profit. http://kraspharma.ru/en/